Proteomics reveals new biological insights
The majority of investigations that reveal a deep mechanistic understanding of disease, genetic variation and drug mechanism of action require direct analysis of proteins, their modifications and their interaction partners.
Focused analyses of biological and clinical systems using mass spectrometry–based technologies detect, identify and quantify proteins and their modifications and interaction partners in cells and tissues under drug treatment or development or during disease perturbation. In this way, MS-based proteomics directly measures the impact and integrative consequences of genomic alterations. When these analyses are combined with specific chemistries, researchers gain insights into the mechanism of action of drugs, the identities of potential new therapeutic targets and new biological knowledge.
The three speakers selected by the editorial leadership of Molecular & Cellular Proteomics to present their work at Discover BMB are a mix of early-career and established investigators who are pushing the boundaries of mass spectrometry–based proteomics combined with elegant chemistries to provide new biological and clinical knowledge.
Katherine Donovan is a group leader and lead scientist at the Dana–Farber Cancer Institute. Her focus is on development and application of targeted proteome degradation and on deepening our understanding of the ubiquitin proteasome system for therapeutic purposes. Read more about Katherine Donovan.
Jim Wells is a professor of pharmaceutical chemistry at the University of California, San Francisco. He focuses on understanding and modulating signaling processes in human cells through protein and small-molecule design. He is especially interested in the interprotein circuitry of pathways involved in cell death and inflammation and the intraprotein allosteric circuitry that governs how distant functional sites in one protein communicate. Read more about Jim Wells.
Lan Huang is a professor of physiology and biophysics in the School of Medicine at the University of California, Irvine. Her research focuses on developing and employing novel mass spectrometry–based proteomic strategies for comprehensive analysis of macromolecular protein complexes to define their composition, heterogeneity, modification, interaction and structure. Read more about Lan Huang.
Donovan, Wells and Huang will present their research at a symposium chaired by Steven Carr on Tuesday, March 28, 2:15 to 3:45 p.m., at Discover BMB.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Tansey named department chair
He has been a faculty member at Otterbein University since 2002.
In memoriam: Joel Habener
He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.
In memoriam: Walter A. Shaw
He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.
Dorn named assistant professor
She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.
The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.
Building a career in nutrition across continents
Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.